Prime Medicine and Myeloid Therapeutics Announce Settlement of Pending Disputes ...Middle East

PR Newswire - News
Prime Medicine and Myeloid Therapeutics Announce Settlement of Pending Disputes
CAMBRIDGE, Mass., Jan. 5, 2024 /PRNewswire/ -- Prime Medicine, Inc. (Nasdaq: PRME) ("Prime Medicine") and Myeloid Therapeutics, Inc. ("Myeloid"), today announced resolution of all of their outstanding disputes, signaling an end to the pending arbitrations and a positive outcome for both...

Hence then, the article about prime medicine and myeloid therapeutics announce settlement of pending disputes was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Prime Medicine and Myeloid Therapeutics Announce Settlement of Pending Disputes )

Apple Storegoogle play

Last updated :

Also on site :